Home LiteratureArticle Details
PMID: 11183578 Published · ppublish English Case Reports Letter

Sildenafil in primary pulmonary hypertension.

The New England journal of medicine ·Vol. 343 ·No. 18 ·2000-11-02 ·Pages 1342

Prasad S, Wilkinson J, Gatzoulis MA

Abstract

暂无摘要

MeSH Terms
3',5'-Cyclic-GMP Phosphodiesterases/antagonists & inhibitors Administration, Oral Adult Humans Hypertension, Pulmonary/drug therapy Male Phosphodiesterase Inhibitors/therapeutic use Piperazines/therapeutic use Purines Sildenafil Citrate Sulfones
Chemicals
Phosphodiesterase Inhibitors Piperazines Purines Sulfones Sildenafil Citrate 3',5'-Cyclic-GMP Phosphodiesterases
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Prasad S
Wilkinson J
Gatzoulis M A
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
DOI
10.1056/NEJM200011023431814
Published
2000-11-02
Pages
1342
Language
English
Region
United States
NLM ID
0255562
Subset
IM
External Links
PubMed source DOI: 10.1056/NEJM200011023431814 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2